Skip to main content

Table 3 Most frequently emerging T-cell receptor (TCR) β sequences that constituted a proportion greater than 5% of all sequences

From: V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients

Sample*

CDR3 amino acid sequence

CDR3 length (nt)

Percentage

V gene

J gene

D gene

R1

CASSEALNNEQFF

39

17.76%

TRBV2

TRBJ2–1

TRBD2

 

CAKGRVPYEQYF

36

6.83%

TRBV2

TRBJ2–7

TRBD2

R2

CACSASSSYEQYF

39

14.16%

TRBV2

TRBJ2–7

TRBD2

 

CASSYSSQEQFF

36

5.33%

TRBV6–3

TRBJ2–1

TRBD1

R4

CATMGGYTF

27

7.71%

TRBV6–5

TRBJ1–2

TRBD1

NR1

CASSFSPHEQYF

36

9.43%

TRBV28

TRBJ2–7

TRBD1

 

CASSLGSQAEAFF

39

8.21%

TRBV7–8

TRBJ1–1

TRBD1

 

CASSPDRGDEQFF

39

6.23%

TRBV12–3

TRBJ2–1

TRBD1

NR3

CASSSGQDTEAFF

39

8.56%

TRBV9

TRBJ1–1

TRBD1

 

CASSPQGAYEQYF

39

8.39%

TRBV9

TRBJ2–7

TRBD1

  1. *R3 and NR2: no clonotype with a frequency > 5%